Clinical Trial Update: Arginine and Nitric Oxide (NO) Early Prognostic Markers for Non-union Development

View source ↗

Summary

Maastricht University Medical Center is conducting a study to evaluate arginine and nitric oxide as early prognostic markers for fracture nonunion development.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fracture Healing
• Fracture Nonunion

Drugs mentioned

• L-Arginine (L-Arginine)

Snippet

Sponsor: Maastricht University Medical Center | Conditions: Fracture Healing, Atrophic Non Union Development | Status: UNKNOWN